BRIEF published on 09/03/2024 at 17:05, 2 months 17 days ago E2Gold Appoints New CFO Financial Management Capital Markets E2Gold New CFO Kyle Nazareth
PRESS RELEASE published on 09/03/2024 at 17:00, 2 months 17 days ago E2Gold Appoints New CFO E2Gold Inc. appoints Kyle Nazareth of Branson Corporate Services as CFO, succeeding Carmelo Marrelli. Nazareth brings extensive finance and capital markets expertise CFO Capital Markets Finance E2Gold Inc. Kyle Nazareth
BRIEF published on 08/27/2024 at 15:05, 2 months 24 days ago E2Gold Closes Financing Private Placement TSX Venture Exchange Financing Gold Exploration Hawkins Project
PRESS RELEASE published on 08/27/2024 at 15:00, 2 months 24 days ago E2Gold Closes Financing E2Gold Inc. announces the closing of a private placement, raising $386,450 through the issuance of units and flow-through units. Proceeds to be allocated for Hawkins project exploration Private Placement Units E2Gold Inc. Flow-through Units Hawkins Project
BRIEF published on 08/23/2024 at 21:37, 2 months 28 days ago E2Gold Inc. Updates on Upcoming Private Placement Private Placement TSX Venture Exchange E2Gold Inc. Hawkins Project Units And FT Units
PRESS RELEASE published on 08/23/2024 at 21:32, 2 months 28 days ago E2Gold Provides Update on Private Placement E2Gold Inc. announces expected closing of private placement to raise up to $500,000. Offering includes Units and FT Units. Funds will be used for Hawkins project exploration Private Placement Units E2Gold Inc. FT Units Hawkins Project
BRIEF published on 07/24/2024 at 14:05, 3 months 27 days ago E2Gold Announces Kinross Intends To Maintain Its 9.9% Stake In Private Placement Private Placement Gold Exploration E2Gold Kinross Gold McKinnon Zone
PRESS RELEASE published on 07/24/2024 at 14:00, 3 months 28 days ago E2Gold Announces Kinross Intends To Maintain Its 9.9% Stake In Private Placement E2Gold Inc. extends financing closing date to August 15, 2024 with Kinross Gold maintaining 9.9% equity position. Focus on growth with new drill program for McKinnon Zone Financing Drill Program E2Gold Inc. Kinross Gold McKinnon Zone
BRIEF published on 06/12/2024 at 22:05, 5 months 8 days ago E2Gold Announces Financing and Corporate Update Financing Corporate Update E2Gold Equity Placement McKinnon Project
PRESS RELEASE published on 06/12/2024 at 22:00, 5 months 8 days ago E2Gold Announces Financing and Corporate Update E2Gold Inc. announces plans to raise $500,000 through an equity private placement for drilling on Hawkins Project. Board member resignation mentioned. Includes details on unit pricing and usage of funds Resignation Drilling E2Gold Inc. Equity Private Placement Hawkins Project
Published on 11/21/2024 at 13:30, 34 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 34 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 29 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 49 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 6 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 44 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
